Lexington, KY, United States of America

Hans Peter Spielmann

This inventor holds 22 USPTO granted patents, primarily in Photodecontamination Technologies. Top assignees: Cerus Corporation, Steritech, Inc., University of Kentucky Research Foundation. Active years: 1995-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans Peter Spielmann. Retrieved from https://idiyas.com/inventor/hans-peter-spielmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 90.9

Average Co-Inventor Count = 3.9

ph-index = 17

Forward Citations = 474(Granted Patents)


Location History:

  • Berkeley, CA (US) (1995 - 2001)
  • Lexington, KY (US) (1997 - 2010)

Company Filing History:


Years Active: 1995-2010

Loading Chart...
Areas of Expertise:
Antibodies
Prenylation Enzymes
Photodecontamination
Pathogens
Psoralen Compounds
Farnesyl Pyrophosphate
Platelet Compositions
Photoactivation
22 patents (USPTO):Explore Patents

Title: Innovations by Hans Peter Spielmann: A Visionary in the Field of Biochemistry

Introduction: Hans Peter Spielmann, based in Lexington, KY, is a prominent inventor holding an impressive portfolio of 22 patents. His contributions to the fields of biochemistry and molecular biology have led to significant advancements in the detection and isolation of proteins, as well as in pathogen inactivation methods. Spielmann’s innovations serve to enhance safety and effectiveness in various applications.

Latest Patents: Some of Hans Peter Spielmann's latest patents showcase his cutting-edge work. One significant patent focuses on "Antibodies and unnatural substrates of prenylation enzymes for use in detecting and isolating prenylated proteins." This invention provides unique moieties that are essential for screening inhibitors of prenylation enzymes. Another noteworthy patent revolves around "Compounds for the photodecontamination of pathogens in blood." This invention details psoralen compound compositions designed to bind to nucleic acids of pathogens, allowing for effective inactivation through covalent crosslinking, thus enhancing both safety and reliability in pathogen management.

Career Highlights: Throughout his career, Spielmann has made impactful contributions while working with leading companies in the biotechnology sector. Notably, he has been associated with Cerus Corporation and Steritech, Inc., both of which have benefitted from his expertise. His innovative spirit and dedication to research have earned him recognition in the scientific community.

Collaborations: Hans Peter Spielmann has collaborated with notable professionals in his field, including Susan Wollowitz and Stephen T Isaacs. These collaborations have fostered a dynamic exchange of ideas and methodologies, further advancing the research and development in their areas of expertise.

Conclusion: Hans Peter Spielmann stands out as an influential figure in the realm of biochemistry and molecular biology. With a remarkable record of patents and collaborations, he continues to push the boundaries of innovation. His work not only enhances the scientific understanding of prenylation enzymes and pathogen inactivation but also supports the development of safer and more effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…